1. Home
  2. KG vs NMRA Comparison

KG vs NMRA Comparison

Compare KG & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KG
  • NMRA
  • Stock Information
  • Founded
  • KG N/A
  • NMRA 2019
  • Country
  • KG Bermuda
  • NMRA United States
  • Employees
  • KG N/A
  • NMRA N/A
  • Industry
  • KG Property-Casualty Insurers
  • NMRA
  • Sector
  • KG Finance
  • NMRA
  • Exchange
  • KG Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • KG 225.0M
  • NMRA 268.5M
  • IPO Year
  • KG N/A
  • NMRA 2023
  • Fundamental
  • Price
  • KG $25.84
  • NMRA $1.83
  • Analyst Decision
  • KG
  • NMRA Hold
  • Analyst Count
  • KG 0
  • NMRA 8
  • Target Price
  • KG N/A
  • NMRA $5.83
  • AVG Volume (30 Days)
  • KG 45.8K
  • NMRA 482.3K
  • Earning Date
  • KG 11-15-2025
  • NMRA 11-11-2025
  • Dividend Yield
  • KG N/A
  • NMRA N/A
  • EPS Growth
  • KG N/A
  • NMRA N/A
  • EPS
  • KG 9.13
  • NMRA N/A
  • Revenue
  • KG $9,983,137.00
  • NMRA N/A
  • Revenue This Year
  • KG N/A
  • NMRA N/A
  • Revenue Next Year
  • KG N/A
  • NMRA N/A
  • P/E Ratio
  • KG $2.81
  • NMRA N/A
  • Revenue Growth
  • KG 250.18
  • NMRA N/A
  • 52 Week Low
  • KG $20.51
  • NMRA $0.61
  • 52 Week High
  • KG $36.80
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • KG 40.59
  • NMRA 57.65
  • Support Level
  • KG $25.47
  • NMRA $1.70
  • Resistance Level
  • KG $27.75
  • NMRA $1.89
  • Average True Range (ATR)
  • KG 1.08
  • NMRA 0.14
  • MACD
  • KG -0.20
  • NMRA 0.01
  • Stochastic Oscillator
  • KG 10.11
  • NMRA 75.93

About KG Kestrel Group Ltd.

Kestrel Group Ltd is specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: